BOULDER, Colo.–(BUSINESS WIRE)—- $BDSX #patientsfirst–Biodesix, Inc. (Nasdaq: BDSX), a leading data-driven diagnostic solutions company with a focus in lung disease, announced today that Scott Hutton, Chief Executive Officer of Biodesix, will present and host in-person 1×1 investor meetings at the Canaccord Genuity 43rd Annual Growth Conference, which will be held from August 7-10, 2023. Canaccord Genuity 43rd Annual Growth Conference Fireside Chat Date: Wednesday, August 9, 2023 Fireside Chat Time: 4:00 PM ET Loca
Click here to view original post
News
NRT BEHAVIORAL HEALTH PROGRAMS TO ACCEPT COLORADO ACCESS AND COLORADO COMMUNITY HEALTH ALLIANCE PLANS
BROOMFIELD, Colo., Nov. 20, 2025 /PRNewswire/ — NRT Behavioral Health treatment programs, which include Foundry Steamboat, Foundry Front Range, and Foundry Outpatient Steamboat, will soon accept Colorado Access and Colorado Community Health Alliance health plans. […]
News
ALLOSOURCE® ADDS QUADRICEP TENDONS TO ITS ALLOCONNEX™ LINE OF TENDONS, LIGAMENTS AND FASCIA
CENTENNIAL, Colo., July 12, 2022 /PRNewswire/ — AlloSource®, one of the largest allograft providers in the U.S., creating innovative cellular and tissue allografts to help surgeons heal their patients, today announced the addition of a […]
News
Report: Colorado businesses avoided costly programs, policies in 2023 legislative session
Colorado Chamber of Commerce’s annual report highlights wins in this year’s session. Click here to view original post
